Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00451152 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma
A Phase 2 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 89
- Enrollment target
NCT00451152: Completed Phase 2 study, sponsored by Alcon Research.
NCT00451152 is a Phase 2 study that has completed, run by Alcon Research. The registered enrollment target is 89 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (33% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00451152, a Phase 2 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the safety and intraocular pressure (IOP)-lowering efficacy of anecortave acetate for treatment of elevated IOP in patients with open-angle glaucoma.
Interventions
- DRUG Anecortave Acetate Sterile Suspension, 30 mg/mL
- OTHER Anecortave Acetate Vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
What the finished NCT00451152 record still lists
NCT00451152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (33% lower).
The record links to 0 conditions, and to 2 interventions - of which Anecortave Acetate Sterile Suspension, 30 mg/mL is the first listed.
NCT00451152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00451152 about?
NCT00451152 is a clinical study titled "Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma". The purpose of this study was to evaluate the safety and intraocular pressure (IOP)-lowering efficacy of anecortave acetate for treatment of elevated IOP in patients with open-angle glaucoma.
What is the current status of trial NCT00451152?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 89 participants. The study started on 2007-03. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00451152?
The interventions under investigation include: Anecortave Acetate Sterile Suspension, 30 mg/mL (DRUG), Anecortave Acetate Vehicle (OTHER).
Who is sponsoring clinical trial NCT00451152?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00451152's enrollment target sits among peer trials
89 802nd of 2000 higher than 1,198 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia